Are alanine aminotransferase 36 U/L and aspartate aminotransferase 21 U/L normal in a 60‑year‑old woman, and what follow‑up is needed?

Are These Liver Enzyme Values Normal in a 60-Year-Old Woman?

Yes, an ALT of 36 U/L and AST of 21 U/L are completely normal in a 60-year-old woman, and no follow-up is needed based on these values alone.

---

Understanding Normal Reference Ranges by Age and Sex

The key to interpreting these values lies in recognizing that normal ALT and AST ranges are significantly lower in women than in men and decline further with advancing age 1, 2.

Sex-Specific Upper Limits of Normal

• For women, the upper limit of normal (ULN) for ALT ranges from 19–25 U/L in most well-designed studies using healthy reference populations 1, 3, 4.
• For AST in women, the ULN is approximately 26–33 U/L 5, 6, 4.
• The patient's ALT of 36 U/L is mildly elevated (approximately 1.4–1.9× the female ULN), while her AST of 21 U/L is well within the normal range 1, 3, 4.

Age-Related Decline in ALT

• ALT levels decline progressively with age in both sexes 2.
• In women aged 50–90 years, the 95th percentile for ALT drops from 26.1 U/L at age 50 to 17.8 U/L at age 90 2.
• At age 60, the expected 95th percentile for ALT in women is approximately 23–24 U/L, making this patient's value of 36 U/L mildly elevated but not alarming 2.

---

Clinical Significance of This Pattern

AST:ALT Ratio

• The AST:ALT ratio is 0.58 (21 ÷ 36), which is <1 and indicates a hepatocellular pattern if liver disease were present 1.
• This ratio is characteristic of non-alcoholic fatty liver disease (NAFLD), viral hepatitis, or medication-induced liver injury rather than alcoholic liver disease (which typically shows AST:ALT >2) 1.

Magnitude of Elevation

• Mild ALT elevation is defined as <5× ULN 1.
• Using a female ULN of 25 U/L, 5× ULN = 125 U/L; this patient's ALT of 36 U/L is only 1.4× ULN, representing a very mild elevation 1.
• ALT elevations of this magnitude are extremely common in the general population and are frequently associated with metabolic risk factors (obesity, diabetes, dyslipidemia) rather than significant liver disease 1, 3.

---

When to Pursue Further Evaluation

Although these values are essentially normal, certain clinical contexts would warrant further investigation 1:

Red Flags Requiring Work-Up

• Symptoms of liver disease: fatigue, jaundice, pruritus, right upper quadrant pain, or signs of hepatic decompensation 1.
• Risk factors for liver disease: excessive alcohol consumption (≥20 g/day in women), known viral hepatitis, family history of liver disease, or use of hepatotoxic medications 1, 3.
• Metabolic syndrome components: obesity (BMI >30), diabetes, hypertension, or dyslipidemia—all of which increase the likelihood of NAFLD 1, 3.
• Persistent elevation: if ALT remains elevated on repeat testing 2–4 weeks later, further evaluation is reasonable 1.

Initial Evaluation if Pursued

If clinical suspicion exists, the American College of Radiology recommends 1:

1. Repeat liver enzymes in 2–4 weeks to establish a trend 1.
2. Complete liver panel: AST, ALT, alkaline phosphatase, total and direct bilirubin, albumin, and prothrombin time 1.
3. Viral hepatitis serologies: HBsAg, anti-HBc IgM, and anti-HCV 1.
4. Metabolic parameters: fasting glucose or HbA1c, fasting lipid panel 1.
5. Abdominal ultrasound: if elevation persists, to assess for hepatic steatosis (sensitivity 84.8%, specificity 93.6% for moderate-to-severe steatosis) 1.

---

Common Pitfalls to Avoid

• Do not use the outdated "universal" ULN of 40 U/L for women; this threshold misses a substantial proportion of women with early liver disease because their normal range is much lower 1, 3, 4.
• Do not assume that mild ALT elevation always requires extensive work-up; in asymptomatic individuals without risk factors, observation with repeat testing is often appropriate 1.
• Do not overlook medications and supplements; even over-the-counter drugs and herbal products can cause mild transaminase elevations 1.
• Do not ignore metabolic risk factors; NAFLD is the most common cause of mild ALT elevation in developed countries and is strongly associated with obesity, diabetes, and dyslipidemia 1, 3.

---

Bottom Line

For this 60-year-old woman with ALT 36 U/L and AST 21 U/L, no immediate action is required if she is asymptomatic and has no risk factors for liver disease. If metabolic syndrome components or other risk factors are present, consider repeating liver enzymes in 2–4 weeks and obtaining a basic metabolic and viral hepatitis work-up 1. The AST value of 21 U/L is entirely normal and requires no further consideration 5, 6, 4.